Non-dilutive funding can play a key role in a life science organization’s financial strategy. The money available annually for extramural research from US government agencies is substantial; approximately $50 billion is budgeted for grants for various programs. Programs may be funded throughout the entire R&D process, and the grants reflect the depth of the various stages.
The National Institutes of Health (NIH) and the Department of Defense (DoD) are the largest sources of funding from the US government. Of the 27 institutes in the NIH, 24 have non-dilutive funding opportunities for R&D. Each of the awarding institutes have defined research aims and objectives, which translate into various funding mechanisms for extramural research. The NIH’s current (2018) budget is approximately $39.1B, and $31B of this budget is allocated to extramural research.
The DoD also has various funding mechanisms available from different agencies – Defense Threat Reduction Agency (DTRA), Defense Advanced Research Projects Agency (DARPA), and the US Army. Other government agencies with funding opportunities include the Biomedical Advanced Research and Development Authority (BARDA), Centers for Disease Control (CDC), and the National Science Foundation (NSF).
To learn more about the various funding opportunities, join us at the Non-Dilutive Funding Summit this January. The Non-Dilutive Funding Summit is a free, educational event that brings representatives of government agencies to discuss funding opportunities, programs, and research objectives. These agencies include NIH institutes, DTRA, BARDA, and US Army, as well as companies who have been successful in securing non-dilutive funding.
The 15th annual Non-Dilutive Funding Summit will take place during JP Morgan Healthcare Week in San Francisco on Wednesday, January 15th, 2020 at the Marines’ Memorial Club.
For more information or to register, click here.
About the FreeMind Group: The FreeMind Group was established in 1999, and is one of the largest consulting group for non-dilutive funding for the life sciences from US government agencies and private foundations. The FreeMind Group works with both academia and industry, from small startups to large pharmaceutical companies and everything in between.